Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of women in the U.S.
Related Posts
Earnings kick into high gear to start February amid ongoing trade worries
Investors will wade through a barrage of quarterly results in the midst of continued policy uncertainty that promises upheaval for an already choppy market.
Trump says D.C. military parade protesters will be met with ‘very heavy force’
President Trump’s warning comes after he deployed National Guard troops and Marines to Los Angeles in response to protests over immigration enforcement efforts.
U.S. payroll growth totals 151,000 in February, less than expected
Nonfarm payrolls were expected to increase 170,000 in February, according to the Dow Jones consensus forecast.